Suppr超能文献

12岁及以上人群的肌酸摄入量与肝脏疾病表现

Creatine consumption and liver disease manifestations in individuals aged 12 years and over.

作者信息

Todorovic Nikola, Korovljev Darinka, Stajer Valdemar, Jorga Jagoda, Ostojic Sergej M

机构信息

Applied Bioenergetics Lab, Faculty of Sport and Physical Education University of Novi Sad Serbia.

Department of Hygiene and Medical Ecology, School of Medicine University of Belgrade Serbia.

出版信息

Food Sci Nutr. 2022 Nov 18;11(2):1134-1141. doi: 10.1002/fsn3.3151. eCollection 2023 Feb.

Abstract

Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross-sectional population-based study was to evaluate the association between creatine intake through regular diet and liver disease manifestations, including liver fibrosis and hepatic steatosis, among individuals aged 12 years and over, using open-source data from the 2017-2018 U.S. National Health and Nutrition Examination Survey (NHANES). A total of 9254 male and female participants of all ages were included in the 2017-2018 NHANES round. We extracted data from the total sample population for participants who provided dietary data for individual foods via dietary interviews and examination data from liver ultrasound transient elastography. The final study sample consisted of 5957 participants (mean age 44.7 ± 21.0 years; 50.1% women), and the mean dietary creatine intake across the study population was 0.88 ± 0.71 g/day. Liver fibrosis and cirrhosis were diagnosed in 1703 (28.7%) and 288 (4.8%) participants, respectively; hepatic steatosis was identified in 2595 (43.7%) individuals. Binary logistic regression with multivariable model adjusted for age, gender, family income to poverty ratio, body mass index, total energy intake, and alcohol consumption showed that consuming more creatine (≥2 g/day) did not significantly increase the risk of liver fibrosis (OR = 0.92, 95% CI 0.70-1.21,  = .57), cirrhosis (OR = 0.94, 95% CI 0.53-1.65,  = .82), or hepatic steatosis (OR = 0.77, 95% CI 0.59-1.02,  = .07), as compared to participants who ingested <1 g of creatine daily. Dietary exposure to creatine through a regular diet is not associated with an increase in disease manifestations in individuals 12 years and over; further research is warranted to address the effects of excessive creatine intake (≥5 g/day) through a regular diet on liver health at the population level.

摘要

尽管有大量关于在各种情况下摄入肌酸的安全性证据,但在人群层面上,饮食中的肌酸是否会影响肝脏健康的信息仍不完整。这项基于人群的横断面研究的主要目的是,利用2017 - 2018年美国国家健康与营养检查调查(NHANES)的开源数据,评估12岁及以上个体通过日常饮食摄入肌酸与肝病表现(包括肝纤维化和肝脂肪变性)之间的关联。2017 - 2018年NHANES轮次共纳入了9254名各年龄段的男性和女性参与者。我们从通过饮食访谈提供了个体食物饮食数据的参与者的总样本人群中提取数据,并从肝脏超声瞬时弹性成像检查数据中提取信息。最终的研究样本包括5957名参与者(平均年龄44.7±21.0岁;50.1%为女性),研究人群的平均饮食肌酸摄入量为0.88±0.71克/天。分别有1703名(28.7%)和288名(4.8%)参与者被诊断为肝纤维化和肝硬化;2595名(43.7%)个体被确定为肝脂肪变性。在对年龄、性别、家庭收入与贫困率、体重指数、总能量摄入和酒精消费进行多变量模型调整的二元逻辑回归分析显示,与每天摄入肌酸<1克的参与者相比,摄入更多肌酸(≥2克/天)并没有显著增加肝纤维化(比值比=0.92,95%置信区间0.70 - 1.21,P = 0.57)、肝硬化(比值比=0.94,95%置信区间0.53 - 1.65,P = 0.82)或肝脂肪变性(比值比=0.77,95%置信区间0.59 - 1.02,P = 0.07)的风险。通过日常饮食摄入肌酸与12岁及以上个体疾病表现的增加无关;有必要进一步研究在人群层面上通过日常饮食过量摄入肌酸(≥5克/天)对肝脏健康的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ac0/9922125/445068b42dff/FSN3-11-1134-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验